PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

CUSIP: 69366J200

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
81,782,297
Total 13F shares
78,779,105
Share change
+1,101,924
Total reported value
$4,025,030,193
Put/Call ratio
70%
Price per share
$50.96
Number of holders
260
Value change
+$67,568,904
Number of buys
133
Number of sells
117

Security key

69366J200

Report period

Q1 2025

Institutions

260

Top holders

10

Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
6.9%
from 13D/G
6,378,000
$287,902,920 31 Dec 2024
Camber Capital Management LP
13D/G 13F
Company
4.2%
3,200,000
$158,464,000 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
11%
9,178,822
$414,332,026 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
9.7%
7,898,801
$356,551,878 31 Dec 2024
13F
RTW INVESTMENTS, LP
13F
Company
9%
7,393,127
$333,725,753 31 Dec 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
5.9%
4,787,123
$216,090,731 31 Dec 2024
13F
TORONTO DOMINION BANK
13F
Company
4%
3,286,729
$148,362,947 31 Dec 2024
13F
STATE STREET CORP
13F
Company
3.3%
2,707,996
$122,238,939 31 Dec 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
2.8%
2,325,915
$105,015,067 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
1,797,016
$81,136,652 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
1.9%
1,542,292
$69,619,061 31 Dec 2024
13F
Point72 Asset Management, L.P.
13F
Company
1.8%
1,443,362
$65,153,361 31 Dec 2024
13F
FRANKLIN RESOURCES INC
13F
Company
1.6%
1,278,188
$57,697,406 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
1.3%
1,077,794
$48,651,621 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
1.3%
1,073,817
$48,472,122 31 Dec 2024
13F
UBS Group AG
13F
Company
1.3%
1,071,051
$48,347,243 31 Dec 2024
13F
Blackstone Inc.
13F
Company
1.3%
1,059,574
$47,829,170 31 Dec 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.3%
1,041,059
$46,993,403 31 Dec 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
1%
826,519
$37,309,068 31 Dec 2024
13F
FMR LLC
13F
Company
1%
820,044
$37,016,787 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.93%
764,625
$34,515,172 31 Dec 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.9%
736,388
$33,240,554 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.89%
727,976
$32,860,836 31 Dec 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.86%
700,000
$31,598,000 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.84%
685,709
$30,952,904 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.8%
653,100
$29,480,934 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.79%
649,269
$29,308,004 31 Dec 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.71%
584,326
$26,377,000 31 Dec 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.69%
568,364
$25,655,951 31 Dec 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.62%
509,204
$22,987,000 31 Dec 2024
13F
Rockefeller Capital Management L.P.
13F
Company
0.6%
492,420
$22,227,839 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.56%
458,015
$20,674,797 31 Dec 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.54%
439,670
$19,846,704 31 Dec 2024
13F
MPM BioImpact LLC
13F
Company
0.53%
434,767
$19,625,382 31 Dec 2024
13F
Palo Alto Investors LP
13F
Company
0.47%
386,413
$17,442,683 31 Dec 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.44%
361,644
$16,324,610 31 Dec 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.44%
360,442
$16,270,352 31 Dec 2024
13F
Trexquant Investment LP
13F
Company
0.38%
313,417
$14,147,643 31 Dec 2024
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.38%
312,016
$14,084,402 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.38%
309,423
$13,967,354 31 Dec 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.38%
306,756
$13,846,966 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.31%
256,536
$11,580,035 31 Dec 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.28%
230,131
$10,388,113 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.27%
216,882
$9,790,045 31 Dec 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.25%
208,302
$9,402,753 31 Dec 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.24%
192,481
$8,688,592 31 Dec 2024
13F
Parkman Healthcare Partners LLC
13F
Company
0.22%
177,368
$8,006,392 31 Dec 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.21%
173,352
$7,825,109 31 Dec 2024
13F
Russell Investments Group, Ltd.
13F
Company
0.21%
170,697
$7,705,301 31 Dec 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.2%
165,918
$7,489,539 31 Dec 2024
13F

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q1 2025

As of 31 Mar 2025, PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) was held by 260 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 78,779,105 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., RTW INVESTMENTS, LP, ARMISTICE CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, TORONTO DOMINION BANK, STATE STREET CORP, FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 259 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
237
Q1 2025 holders
260
Holder diff
23
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .